See the DrugPatentWatch profile for mirtazapine
Mirtazapine, a medication used to treat depression, has undergone review and approval by the U.S. Food and Drug Administration (FDA) [1]. The FDA's New Drug Application (NDA) process is how drug manufacturers seek approval to market a new drug in the United States [2].
What is Mirtazapine used for?
Mirtazapine is primarily prescribed for the treatment of major depressive disorder [3]. It works by affecting the activity of certain chemicals in the brain that are believed to be involved in depression [4].
How does the FDA approve new drugs like Mirtazapine?
The FDA's approval of a new drug, such as mirtazapine through its NDA, signifies that the agency has determined the drug is safe and effective for its intended use based on scientific evidence [2]. This rigorous evaluation involves reviewing extensive data from preclinical studies and clinical trials [2].
When did Mirtazapine first receive FDA approval?
Mirtazapine was first approved by the FDA in 1996 [3].
Are there different forms or brands of Mirtazapine available?
Mirtazapine is available in both generic and brand-name forms [3].
What is the patent status of Mirtazapine?
Information regarding the patent status and expiry dates for mirtazapine can be found on resources that track drug patents [5]. Patent protection is crucial for pharmaceutical companies as it grants them exclusive rights to their inventions for a set period, influencing market exclusivity and the potential for generic competition [6].
Who manufactures Mirtazapine?
Various pharmaceutical companies manufacture and market mirtazapine, both as a brand-name product and as a generic alternative [3].